Assessment of Viral Shedding in Children Previously in Receipt of Multiple Doses of Live Attenuated Influenza Vaccine (LAIV) Compared to Influenza Vaccine-naïve Controls (Flushed)
Sponsor: Public Health England
This PHASE4 trial investigates Influenza and Influenza Vaccination and is currently completed. Public Health England leads this study, which shows 7 recorded versions since 2017 — indicating limited longitudinal coverage. Longitudinal tracking of infectious disease trials helps identify durability of treatment effects.
Status Flow
Change History
7 versions recorded-
Sep 2024 — Present [monthly]
Completed PHASE4
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE4
-
Jan 2021 — Jul 2024 [monthly]
Completed PHASE4
-
Sep 2019 — Jan 2021 [monthly]
Completed PHASE4
-
Apr 2019 — Sep 2019 [monthly]
Completed PHASE4
Status: Not Yet Recruiting → Completed
▶ Show 2 earlier versions
-
Jun 2018 — Apr 2019 [monthly]
Not Yet Recruiting PHASE4
-
May 2017 — Jun 2018 [monthly]
Not Yet Recruiting PHASE4
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Public Health England
For direct contact, visit the study record on ClinicalTrials.gov .